Dr. Luc Duchesne

About Dr. Luc Duchesne

Dr. Luc C. Duchesne is a Speaker and Author with a PhD in Biochemistry. With three decades of scientific and business experience, he has published 85 scientific papers, and has recently published his first novel, "The Moose Motel: A Tale of Golden Revenge". The Founder and CEO for GSN DreamWorks Inc. based in Ottawa, Luc is a regular columnist for InvestorIntel.

171 InvestorIntel Articles By Dr. Luc Duchesne


iAnthus capital steps in for a state-of-the-art cannabis cultivation and processing facility in Massachusetts

April 19, 2017
| April 19, 2017

iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE: IAN), a provider of capital investment and management services to licensed […]

The hafnium truth about keeping nuclear energy cool

April 10, 2017
| April 10, 2017 | 1 Comment

Alkane Resources Ltd.’s (ASX: ALK | OTCQX: ANLKY) Dubbo project is expected to resolve the shortfall of hafnium production and push […]

Vastly under-rated hemp market ready to ride cannabis coattails

April 07, 2017
| April 07, 2017 | 2 Comments

Hempco Food and Fiber Inc. (TSXV: HEMP) (“Hempco”) announced its February bulk sales total as $173k and Retail Sales total […]

Major growth in the ‘complex’ health benefits automation market offers shareholder value

April 03, 2017
| April 03, 2017 | 1 Comment

“SEB offers a state of the art solution to this complex environment that lagged in automation.” — Dr. Luc Duchesne […]

InvestorIntel and friends offer condolences to Bernard Tourillon

March 14, 2017
| March 14, 2017 | 1 Comment

The editorial board of InvestorIntel is extending heartfelt condolences to Mr Bernard Tourillon and his family for the passing of […]

Neometals to benefit from emerging vanadium research

February 22, 2017
| February 22, 2017

Neometals Ltd. (ASX: NMT) (“Neometals”) reported it has completed the refurbishment of the laboratory and mini-plant test facility in Montreal […]